21
| Date post: | 03-Jul-2015 |
| Category: |
Healthcare |
| Upload: | beroe-inc |
| View: | 92 times |
| Download: | 1 times |
2
• How to post a question?
• To log in again if the connection is lost, use the link in the confirmation mailer you would have received from [email protected]
• In case you face any other issues write an email to [email protected]
Panel Members:
Dr. Rajesh Jain Clinical Research Consultant Independent Consultant Dialing in from:
India
Moe Alsumidaie President & Chief Scientific Officer Annex Clinical Dialing in from:
USA
Ashwini Tripathi Senior Research Analyst Beroe Inc. Dialing in from:
India
Host
Panel Members for the Webinar
Sharan Ramesh Engagement Manager Beroe Inc. Dialing in from:
India
Moderator
3
Release of Guidelines
15-25%
>35%
15-25%
CRAs will be enabled with analytical skills to identify problematic, missing
data before visiting a site.
41%
On site Monitoring
22%
Off site Monitoring
19%
Travel
13%
Administrative tasks
5%
Training
Lack of proven methodologies can impact the Engagement Model
between sponsor and the service providers
Source: CMR International Pharmaceutical R&D Factbook, 2012
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
Low High
1 5 2 3 4
TransCelerate
•
•
•
ADAMON
•
•
•
OPTIMON
•
•
•
